[1]
|
Cullis, J. (2019) Haematology: Multiple Myeloma. Clinical Medicine, 19, 188-188.
https://doi.org/10.7861/clinmedicine.19-2-188a
|
[2]
|
Pawlyn, C. and Davies, F.E. (2019) Toward Personalized Treatment in Multiple Myeloma Based on Molecular Characteristics. Blood, 133, 660-675. https://doi.org/10.1182/blood-2018-09-825331
|
[3]
|
Mene, P., Giammarioli, E., Fofi, C., et al. (2018) Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury: A Case Series. Kidney & Blood Pressure Research, 43, 1263-1272. https://doi.org/10.1159/000492408
|
[4]
|
Bozic, B., Rutner, J., Zheng, C., et al. (2021) Advances in the Treatment of Relapsed and Refractory Multiple Myeloma in Patients with Renal Insufficiency: Novel Agents, Immunotherapies and Beyond. Cancers, 13, 5036.
https://doi.org/10.3390/cancers13205036
|
[5]
|
Knudsen, L.M., Hjorth, M. and Hippe, E. (2000) Renal Failure in Multiple Myeloma: Reversibility and Impact on the Prognosis. Nordic Myeloma Study Group. European Journal of Haematology, 65, 175-181.
https://doi.org/10.1034/j.1600-0609.2000.90221.x
|
[6]
|
Hsu, P., Lin, T.-W., Gau, J.-P., et al. (2015) Risk of Early Mortality in Patients with Newly Diagnosed Multiple Myeloma. Medicine, 94, e2305. https://doi.org/10.1097/MD.0000000000002305
|
[7]
|
Yan, G., Li, H.M., Zhang, Y.D., et al. (2022) Renal Insuffi-ciency Predicts Worse Prognosis in Newly Diagnosed IgD Multiple Myeloma Patients. Frontiers in Oncology, 12, Ar-ticle ID: 1012889.
https://doi.org/10.3389/fonc.2022.1012889
|
[8]
|
Stompor, T., Zablocki, M. and Pankrac, K. (2012) Renal In-volvement in Multiple Myeloma. Polish Archives of Internal Medicine, 122, 443-448. https://doi.org/10.20452/pamw.1385
|
[9]
|
Mene, P., Stoppacciaro, A., Lai, S., et al. (2022) Light Chain Cast Nephropathy in Multiple Myeloma: Prevalence, Impact and Management Challenges. International Journal of Neph-rology and Renovascular Disease, 15, 173-183.
https://doi.org/10.2147/IJNRD.S280179
|
[10]
|
Kundu, S., Jha, S.B., Rivera, A.P., et al. (2022) Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management. Cureus, 14, e22585. https://doi.org/10.7759/cureus.22585
|
[11]
|
Karam, S. and Leung, N. (2020) Renal Involvement in Systemic Amy-loidosis Caused by Monoclonal Immunoglobulins. Hematology-Oncology Clinics of North America, 34, 1069. https://doi.org/10.1016/j.hoc.2020.08.002
|
[12]
|
Lomas, O.C., Mouhieddine, T.H., Tahri, S., et al. (2020) Mono-clonal Gammopathy of Undetermined Significance (MGUS)-Not So Asymptomatic after All. Cancers (Basel), 12, 1554. https://doi.org/10.3390/cancers12061554
|
[13]
|
Yaday, P., Cockwell, P., Cook, M., et al. (2018) Serum Free Light Chain Levels and Renal Function at Diagnosis in Patients with Multiple Myeloma. BMC Nephrology, 19, Article No. 178. https://doi.org/10.1186/s12882-018-0962-x
|
[14]
|
Xu, J., Wang, M., Shen, Y., et al. (2021) Effects of Amyloid Light-Chain Amyloidosis on Clinical Characteristics and Prognosis in Multiple Myeloma: A Single-Center Retrospective Study. Cancer Management and Research, 13, 1343-1356. https://doi.org/10.2147/CMAR.S287922
|
[15]
|
Kaneko, S., Usui, J., Narimatsu, Y., et al. (2022) Renal Involvement of Monoclonal Immunoglobulin Deposition Disease Associated with an Unusual Monoclonal Immunoglobulin A Glycan Profile (vol. 14, pg 389, 2010). Clinical and Experimental Nephrology, 26, 733-733. https://doi.org/10.1007/s10157-022-02212-1
|
[16]
|
Ying, W.Z. and Sanders, P.W. (2001) Mapping the Binding Domain of Immunoglobulin Light Chains for Tamm-Horsfall Protein. The American Journal of Pathology, 158, 1859-1866. https://doi.org/10.1016/S0002-9440(10)64142-9
|
[17]
|
Anandh, U., Patrick, A. and Sharma, A. (2019) Coexistent Amyloid Fibrils in a Patient with Combined Light Chain Deposition Disease and Light Chain Cast Nephropathy. Indian Journal of Nephrology, 29, 204-206.
https://doi.org/10.4103/ijn.IJN_36_18
|
[18]
|
Morgan, G.J., Buxbaum, J.N. and Kelly, J.W. (2021) Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis. Hemato, 2, 645-659. https://doi.org/10.3390/hemato2040042
|
[19]
|
Sanders, P.W. (2012) Mechanisms of Light Chain Injury along the Tubular Nephron. Journal of the American Society of Nephrology, 23, 1777-1781. https://doi.org/10.1681/ASN.2012040388
|
[20]
|
Cruz-Solbes, A.S. and Youker, K. (2017) Epithelial to Mesenchymal Transition (EMT) and Endothelial to Mesenchymal Transition (EndMT): Role and Implications in Kidney Fibrosis. In: Miller, R.K., Ed., Kidney Development and Disease, Springer, Berlin, 345-372. https://doi.org/10.1007/978-3-319-51436-9_13
|
[21]
|
Sengul, S., Zwizinski, C. and Batuman, V. (2003) Role of MAPK Pathways in Light Chain-Induced Cytokine Production in Human Proximal Tubule Cells. American Journal of Physiology. Renal Physiology, 284, F1245-F1254.
https://doi.org/10.1152/ajprenal.00350.2002
|
[22]
|
Sathick, I.J., Drosou, M.E. and Leung, N. (2019) Myeloma Light Chain Cast Nephropathy, a Review. Journal of Nephrology, 32, 189-198. https://doi.org/10.1007/s40620-018-0492-4
|
[23]
|
Auron, A. and Alon, U.S. (2018) Hypercalcemia: A Consultant’s Approach. Pediatric Nephrology, 33, 1475-1488.
https://doi.org/10.1007/s00467-017-3788-z
|
[24]
|
Xu, L., Zhao, B., Sun, Y., et al. (2022) Using Two Detection Methods to Observe the Changes and Significance of Free Light Chain in Serum and Urine in Patients with Renal In-sufficiency. Biomed Research International, 2022, Article ID: 5536199. https://doi.org/10.1155/2022/5536199
|
[25]
|
Owoyemi, I., Sethi, S. and Leung, N. (2021) Kidney Injury in Multiple Myeloma: A Kidney Biopsy Teaching Case. Kidney Medicine, 3, 303-306. https://doi.org/10.1016/j.xkme.2020.10.013
|
[26]
|
Rana, R., Cockwell, P., Drayson, M., et al. (2020) Renal Outcome in Patients with Newly Diagnosed Multiple Myeloma: Results from the UK NCRI Myeloma XI Trial. Blood Advances, 4, 5836-5845.
https://doi.org/10.1182/bloodadvances.2020002872
|
[27]
|
Yadav, P., Cook, M. and Cockwell, P. (2016) Current Trends of Renal Impairment in Multiple Myeloma. Kidney Diseases, 1, 241-257. https://doi.org/10.1159/000442511
|
[28]
|
刘玲. 多发性骨髓瘤并发急性肾损伤诱因回归分析[J]. 中国现代医药杂志, 2010, 12(3): 92-94.
|